Thursday, 17 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14422
Articles
Company
Drug
Innovent’s Tyvyt Approved for New Gastric Cancer Indication by NMPA
February 2, 2025
Company
Drug
Zhejiang Huahai Receives FDA ANDA Approval for Generic Tecfidera
February 2, 2025
Company
Deals
Novartis Expands Strategic Collaboration with Bo’Ao Lecheng Pilot Zone
February 2, 2025
Company
Deals
Salubris Partners with Alpha Molecular for AI-Driven Obesity Drug Development
February 2, 2025
Company
RemeGen Reports 397.47% YOY Revenue Growth in Q3 2022
February 2, 2025
Company
Drug
Innovent’s Parsaclisib Filed for Marketing Approval in China
February 2, 2025
Company
Drug
Proheal Pharmaceuticals Initiates Clinical Study for PHP1003 in Thyroid-Associated Ophthalmopathy
February 2, 2025
Company
Drug
HutchMed Initiates Phase II/III Study for Elunate and Tyvyt in Renal Cell Carcinoma
February 2, 2025
Company
Shanghai Pharmaceuticals Reports 12.86% YOY Revenue Growth in Q3 2022
February 2, 2025
Company
Drug
Recbio’s Neoadjuvant HPV Vaccine Accepted for Review by NMPA
February 2, 2025
Company
Drug
Kintor Completes Enrollment for GT20029 Phase I Study in US
February 2, 2025
Company
Drug
Alphamab Oncology Gains NMPA Approval for JSKN003 Clinical Trial
February 2, 2025
1
2
…
1,107
1,108
1,109
1,110
1,111
…
1,201
1,202
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
